Society

The Myners Report into the Co-operative Group (pdf) has been published today, and it doesn’t make for pleasant reading. Following the discovery of a £1.5 billion black hole in their finances, followed by the Paul Flowers ‘crystal Methodist’ scandal, the Co-op commissioned the former City Minister Paul Myners to look into the group’s problems and put together a restructuring plan to make it sustainable and properly governed. Here are the key things you need to know from the 180-page report: 1. The Co-op group is still ‘manifestly dysfunctional’ Lord Myners is not impressed with the current state of the Co-op Group and warns it needs to radically change ‘soon’ or

How can political parties solve the housing crisis? The vogue a few years ago was to talk about garden cities, although once it became clear that the National Planning Policy Framework had upset a lot of Conservative voters, politicians started to prevaricate over plans for more garden cities, and then eventually published a ‘prospectus’ asking for locally-led ideas. I spent this morning exploring Milton Keynes, which was a New Town, rather than one of the original garden cities, but which planning policy wonks, including Number 10’s Alex Morton, hold up as an example of a new development built from scratch which has become hugely successful, with high rates of private

Organised atheism is on the rise and this prompted John Whitworth to make the excellent suggestion that I challenge competitors to come up with a hymn for atheists. Hymns do not feature at all at The Sunday Assembly, an atheist Church founded last year in London. Instead the congregation sings along, in evangelical style, to pop songs by the likes of the Pointer Sisters, Stevie Wonder and Daft Punk. Perhaps they might feel inspired, by one of the entries below, to change their tune. There were neat twists on ‘Amazing Grace’, ‘All Things Bright and Beautiful’, ‘Onward Christian Soldiers’, and Milton’s ‘Let us, with a gladsome mind’. I liked Sid

The pattern of the global pharmaceutical industry has long been towards cross-border mergers that combine research strength, market access and the capital needed to sustain new drugs through multinational approval processes.The UK has done well in this game, with excellent laboratory work and two giants still headquartered here, GlaxoSmithKline and AstraZeneca. The latter is part-Swedish but has 6,700 British staff and a heritage that descends from the pharmaceuticals business of ICI, greatest of 20th-century British industrial names. So alarm bells rang with the announcement at the beginning of the week of a takeover bid by Pfizer of the US, which has at least two counts against it: it is suspected